SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs - Quaterly Results

08 Feb 2024 Evaluate
The topline stands at Rs. 314.15 millions for the December 2023 quarter. The mentioned figure indicates a rise of about 83.37% as against Rs. 171.32 millions during the year-ago period.The Total Profit for the quarter ended December 2023 of Rs. 13.64 millions grew from Rs.-102.14 millionsOperating profit surged to 63.77 millions from the corresponding previous quarter of 33.33 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 314.15 171.32 83.37 794.12 611.37 29.89 805.93 1643.49 -50.96
Other Income 5.25 11.14 -52.87 12.57 28.37 -55.69 34.52 27.20 26.91
PBIDT 63.77 33.33 91.33 136.02 157.07 -13.40 190.52 1002.19 -80.99
Interest 12.59 30.42 -58.61 37.63 87.57 -57.03 115.70 199.21 -41.92
PBDT 51.18 -66.06 -177.48 97.94 -0.85 -11622.35 3.08 756.30 -99.59
Depreciation 27.17 33.25 -18.29 95.15 101.94 -6.66 135.16 153.89 -12.17
PBT 24.01 -99.31 -124.18 2.79 -102.79 -102.71 -132.08 602.41 -121.93
TAX 10.37 2.83 266.43 9.27 0.04 23075.00 0.78 203.38 -99.62
Deferred Tax 1.27 -2.72 -146.69 -3.18 -5.51 -42.29 -1.29 203.38 -100.63
PAT 13.64 -102.14 -113.35 -6.48 -102.83 -93.70 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 20.30 19.45 4.34 17.13 25.69 -33.33 23.64 60.98 -61.23

Lyka Labs Share Price

65.10 3.10 (5.00%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×